Alaunos Therapeutics Inc (TCRT) — Working Capital to Net Assets Ratio
Alaunos Therapeutics Inc (TCRT) has a Working Capital to Net Assets ratio of 54.6% as of December 2025. Working capital of $1.18 Million (current assets of $1.99 Million minus current liabilities of $813.00K) is measured against net assets of $2.15 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Alaunos Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Alaunos Therapeutics Inc Working Capital to Net Assets (2002–2025)
This chart shows how Alaunos Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 54.6%, reflecting working capital of $1.18 Million against net assets of $2.15 Million USD. Check TCRT goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Alaunos Therapeutics Inc (2002–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Alaunos Therapeutics Inc from 2002 to 2025, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Alaunos Therapeutics Inc stock valuation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 54.6% | $1.18 Million | $2.15 Million | $1.99 Million | $813.00K | ▼ -45.4 pp |
| 2024 | 100.0% | $2.06 Million | $2.06 Million | $2.75 Million | $692.00K | ▲ +0.0 pp |
| 2023 | 100.0% | $6.30 Million | $6.31 Million | $8.26 Million | $1.96 Million | ▲ +23.1 pp |
| 2022 | 76.9% | $29.63 Million | $38.55 Million | $53.80 Million | $24.17 Million | ▼ -31.3 pp |
| 2021 | 108.2% | $62.79 Million | $58.06 Million | $78.83 Million | $16.04 Million | ▲ +17.6 pp |
| 2020 | 90.5% | $112.22 Million | $123.98 Million | $130.59 Million | $18.37 Million | ▼ -7.3 pp |
| 2019 | 97.8% | $92.97 Million | $95.01 Million | $105.49 Million | $12.53 Million | ▲ +10.4 pp |
| 2018 | 87.4% | $74.80 Million | $85.56 Million | $84.28 Million | $9.48 Million | ▲ +159.7 pp |
| 2017 | -72.2% | $69.93 Million | $-96.81 Million | $90.78 Million | $20.86 Million | ▲ +43.0 pp |
| 2016 | -115.2% | $89.08 Million | $-77.30 Million | $104.88 Million | $15.81 Million | ▼ -269.1 pp |
| 2015 | 153.8% | $134.40 Million | $87.37 Million | $152.52 Million | $18.12 Million | ▲ +55.5 pp |
| 2014 | 98.3% | $33.26 Million | $33.84 Million | $44.09 Million | $10.83 Million | ▼ -28.3 pp |
| 2013 | 126.6% | $62.51 Million | $49.38 Million | $70.30 Million | $7.79 Million | ▼ -0.2 pp |
| 2012 | 126.8% | $61.41 Million | $48.45 Million | $80.28 Million | $18.86 Million | ▼ -2.7 pp |
| 2011 | 129.5% | $92.74 Million | $71.61 Million | $106.11 Million | $13.36 Million | ▼ -57.7 pp |
| 2010 | 187.2% | $57.20 Million | $30.55 Million | $60.82 Million | $3.61 Million | ▲ +23.2 pp |
| 2009 | 164.0% | $46.10 Million | $28.10 Million | $49.19 Million | $3.10 Million | ▲ +76.0 pp |
| 2008 | 88.0% | $5.93 Million | $6.74 Million | $11.71 Million | $5.78 Million | ▼ -8.2 pp |
| 2007 | 96.2% | $29.22 Million | $30.37 Million | $35.53 Million | $6.31 Million | ▼ -1.5 pp |
| 2006 | 97.7% | $25.94 Million | $26.53 Million | $28.87 Million | $2.94 Million | ▲ +2.8 pp |
| 2005 | 94.9% | $6.84 Million | $7.20 Million | $9.09 Million | $2.25 Million | ▼ -5.1 pp |
| 2004 | 100.0% | $-21.02K | $-21.02K | $21.00 | $21.05K | ▲ +0.0 pp |
| 2003 | 100.0% | $-25.69K | $-25.69K | $33.00 | $25.72K | ▼ -2.8 pp |
| 2002 | 102.8% | $-17.82K | $-17.33K | $15.00 | $17.84K | — |